Published in J Cardiovasc Pharmacol on October 01, 1992
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun (1974) 6.53
Insertion of long term central venous catheters: time for a new look. BMJ (1995) 2.92
Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg (1991) 2.62
The future of interventional radiology--does it have one? Clin Radiol (1993) 2.57
Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1972) 2.41
Granuloma formation induced in mice by chemically defined mycobacterial fractions. J Bacteriol (1969) 2.36
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol (2002) 2.14
Intravenous cholangiography revisited. Clin Radiol (1993) 1.99
Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem Biophys Res Commun (1974) 1.82
Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey. Biochim Biophys Acta (1970) 1.73
Tim23 links the inner and outer mitochondrial membranes. Cell (2000) 1.68
Self-expanding metal stents for the palliation of dysphagia due to inoperable oesophageal carcinoma. Br J Surg (1995) 1.66
Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun (1975) 1.64
Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun (1993) 1.63
Use of stents for treating obstruction of urinary outflow in patients unfit for surgery. BMJ (1989) 1.62
Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers. Biochem Biophys Res Commun (1976) 1.60
Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. Mol Cell Biochem (1975) 1.55
Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae. Infect Immun (1975) 1.54
Brittle cornea. A familial trait associated with blue sclera. Am J Ophthalmol (1968) 1.53
Chemical structure of the cell wall of Mycobacterium smegmatis. I. Isolation and partial characterization of the peptidoglycan. Biochem Biophys Res Commun (1969) 1.48
Registration of freehand 3D ultrasound and magnetic resonance liver images. Med Image Anal (2004) 1.44
Dichromats detect colour-camouflaged objects that are not detected by trichromats. Proc Biol Sci (1992) 1.43
Muramyl peptides: immunomodulators, sleep factors, and vitamins. Med Res Rev (1984) 1.40
Mitogenic effect of a water-soluble extract of Nocardia opaca: a comparative study with some bacterial adjuvants on spleen and peripheral lymphocytes of four mammalian species. J Immunol (1974) 1.40
Cerebral mass lesions in patients with AIDS. BMJ (1990) 1.40
Diagnostic iodised oil embolisation of liver tumours--the Hammersmith experience. Eur J Radiol (1993) 1.38
Trans-oral embolization of a post-operative duodenocutaneous fistula. Clin Radiol (2004) 1.38
Interventional radiology in palliative medicine. Br J Hosp Med (1997) 1.38
Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. J Med Genet (2008) 1.36
Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca. Infect Immun (1973) 1.35
Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am J Hum Genet (1973) 1.35
Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology (2000) 1.31
From cradle to early grave: juvenile mortality in European shags Phalacrocorax aristotelis results from inadequate development of foraging proficiency. Biol Lett (2007) 1.25
Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther (2000) 1.24
Linkage relations of X-borne ichthyosis to the Xg blood groups and to other markers of the X in Israelis. Ann Hum Genet (1969) 1.23
The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. J Clin Invest (1998) 1.22
Silica induces apoptosis in macrophages and the release of interleukin-1 alpha and interleukin-1 beta. J Leukoc Biol (1993) 1.21
Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol (2001) 1.21
Patterns of genetic diversity in outcrossing and selfing populations of Arabidopsis lyrata. Mol Ecol (2007) 1.20
Plastic-covered metallic endoprostheses in the management of oesophageal perforation in patients with oesophageal carcinoma. Clin Radiol (1995) 1.20
Glucose-6-phosphate dehydrogenase mosaicism as a tracer in the study of hereditary multiple trichoepithelioma. Am J Hum Genet (1966) 1.19
Muramyl peptides. Chemical structure, biological activity and mechanism of action. Mol Cell Biochem (1981) 1.19
Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett (1998) 1.19
Gianturco expandable metallic biliary stents: results of a European clinical trial. Radiology (1989) 1.19
[Mass spectrometry of glycolipids. 2. Natural and synthetic diesters of trehalose]. Eur J Biochem (1967) 1.18
Treatment of acute viral hepatitis with (+)-cyanidanol-3. Lancet (1977) 1.18
Metallic stents in malignant biliary obstruction: results of a multicenter European study of 240 patients. J Vasc Interv Radiol (1994) 1.17
Use of metallic stents and balloons in the esophagus and gastrointestinal tract. J Vasc Interv Radiol (2001) 1.15
Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases. Q J Med (1970) 1.14
Ganglioneuroblastoma of the posterior mediastinum: a clinicopathologic review of 80 cases. Cancer (1981) 1.12
Monarticular brucellar arthritis in children. J Bone Joint Surg Br (1967) 1.11
Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats. Cell Transplant (2012) 1.10
Influence of vasopressin on learning and memory. Lancet (1978) 1.10
The linkage relation of Xg to g-6-pd in Israelis: the evidence of a second series of families. Ann Hum Genet (1967) 1.08
Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture. Thromb Res (1999) 1.07
The role of metallic stents in malignant duodenal obstruction. Br J Radiol (1997) 1.06
Genetic diseases among Jews. Isr J Med Sci (1974) 1.06
Extensive subcutaneous calcification following injections of pitressin tannate. Br J Radiol (1984) 1.05
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests. Breast Cancer Res Treat (2013) 1.05
Small epithelial cells in human liver cirrhosis exhibit features of hepatic stem-like cells: immunohistochemical, electron microscopic and immunoelectron microscopic findings. Histopathology (2003) 1.05
Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci U S A (1996) 1.04
The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. Peptides (2000) 1.04
Isolation and mass spectrometric identification of the peptide subunits of mycobacterial cell walls. Biochem Biophys Res Commun (1970) 1.04
Effects of captopril and Icatibant on bradykinin (BK) and des [Arg9] BK in carrageenan-induced edema. Peptides (1996) 1.02
Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP). Biochem Biophys Res Commun (1978) 1.01
Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family. Arch Neurol (2001) 1.01
Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology (1999) 1.01
Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment. HIV Med (2002) 1.01
[Oculomotor paralysis and spinal anesthesia]. Ann Fr Anesth Reanim (2001) 1.01
Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates. J Pharmacol Exp Ther (2001) 1.00
Protective effects of delipidated mycobacterial cells and purified cell walls against Ehrlich carcinoma and a syngeneic lymphoid leukemia in mice. Cancer Res (1973) 1.00
The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet (2006) 1.00
Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathways. Br J Pharmacol (1991) 0.99
Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J (2008) 0.98
Genetic aspects of pituitary dwarfism due to absence or biological inactivity of growth hormone. Isr J Med Sci (1969) 0.97
Central bronchogenic cyst: treatment by extrapleural percutaneous aspiration. BMJ (1989) 0.97
Percutaneous liver biopsy and track embolization with steel coils. Radiology (1988) 0.97
Bronchogastric fistula successfully treated with the insertion of a covered bronchial stent. Eur Radiol (2002) 0.97
Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor. Br J Pharmacol (1993) 0.96
Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents. Eur Heart J (2002) 0.96
[Acceleration of the speed of neuronal growth by a new neurotropic substance: N-isopropyl-amino-2-pyrimidine]. C R Acad Sci Hebd Seances Acad Sci D (1977) 0.96
Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours. Cardiovasc Intervent Radiol (2014) 0.96
Gianturco self-expanding stents: clinical experience in the vena cava and large veins. Cardiovasc Intervent Radiol (1992) 0.95
Arthrogryposis multiplex congenita: twenty-three cases in an Arab kindred. Pediatrics (1970) 0.95
[Adjuvant activity of peptidoglyoans from mycobacteria]. C R Acad Sci Hebd Seances Acad Sci D (1974) 0.95
Effect of enalaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischaemic rat heart. Br J Pharmacol (1995) 0.95
X-linked dyskeratosis congenita with pancytopenia. Arch Dermatol (1978) 0.95
Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues. Peptides (1994) 0.95
Congenital deficiency in plasma kallikrein and kininogens in the brown Norway rat. Experientia (1980) 0.94
A novel HPLC method for the simultaneous quantification of monosaccharides and disaccharides used in tests of intestinal function and permeability. Clin Chim Acta (1993) 0.94
Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia. FASEB J (2005) 0.94
Increase in blood bradykinin concentration after eccentric weight-training exercise in men. J Appl Physiol (1985) (1999) 0.94
Malignant esophageal fistulas and perforations: management with plastic-covered metallic endoprostheses. Radiology (1997) 0.94
Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat. Am J Physiol (1996) 0.93
Results of aortocoronary artery saphenous vein bypass surgery for ischemic heart disease. Am J Cardiol (1974) 0.93
A further query on color blindness and natural selection. Soc Biol (1969) 0.93